Prevention, Diagnostic and Antibiotic Treatment of Periprosthetic Joint and Fracture Related Infection, 2nd Edition

Dear Colleagues,

The first Special Issue covering the topic of prevention, diagnosis and treatment of periprosthetic joint and fracture-related infections was very successful.

As such, we want to proceed with the second Special Issue on the same topic.

The aim of this Special Issue is to update the readers with new knowledge about the prevention, diagnostics, surgical and antibiotic treatment of periprosthetic joint and fracture-related infections.

Periprosthetic joint infection (PJI) and fracture-related infection (FRI) are severe complications of joint replacement and trauma surgery. Due to increasing numbers of joint replacements and revision arthroplasties, as well as fracture treatment, the number of PJIs and FRIs increase parallelly. Therefore, the prevention of this severe, expensive and resource-consuming complication is of high importance. Because no test with an accuracy of 100% exists, the diagnosis of possible infection remains a challenge. New markers and techniques are coming on the market, and research in this field of interest is important to rule out or verify these infections before surgery. The therapeutic pathways can be adapted to these differentiations.

The treatment of PJI and FRI is under continuous development and new techniques (for example, the coatings of cementless implants and local antibiotic treatment) coming on the market soon. Moreover, local and systemic antibiotic application is a significant part of successful treatment.

Therefore, we are pleased to invite you to send papers discussing a topic in the field of PJI or FRI prevention, diagnosis and treatment. Original articles or meta-analyses in the clinical field and basic research are welcome, as well as review articles that summarize up-to-date knowledge in the field of this Special Issue.

We look forward to receiving your contributions.

Website link of the first volume: https://www.mdpi.com/journal/antibiotics/special_issues/83001W58W3

Prof. Dr. Bernd Fink
Prof. Dr. Steffen Ruchholtz
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• periprosthetic joint infection
• fracture-related infection
• diagnostic treatment

• Prevention, Diagnostic and Antibiotic Treatment of Periprosthetic Joint and Fracture Related Infection in Antibiotics (11 articles)